ArticleJournal of comparative effectiveness researchPublished
Overall survival in patients with metastatic castration-sensitive prostate cancer treated with apalutamide versus abiraterone acetate: a head-to-head analysis of real-world patients in the USA
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Journal of comparative effectiveness research
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Neoplasm Metastasis; Thiohydantoins; Retrospective Studies; Aged; Aged, 80 and over; Middle Aged; United States; Male; Androgen Receptor Antagonists; Prostatic Neoplasms, Castration-Resistant; Abiraterone Acetate
- PubMed ID
- 40340441
- PubMed Central ID
- PMC12224120
- Open access
- Yes, open
- Added to directory
- Source checked